Antibiotic-resistant salmonella strain reaches Europe

By Admin
Scientists are urging health authorities across the world to act quickly to treat and monitor a new strain of salmonella before it spreads across the w...

Scientists are urging health authorities across the world to act quickly to treat and monitor a new strain of salmonella before it spreads across the world.

The new superbug, known as S. Kentucky, has recently emerged in Europe and has been indentified in France, England, Denmark and the UK.

It is thought the salmonella strain originated in Africa and as it has travelled through the Middle East towards Europe it has picked up drug-resistant properties.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Research has suggested the bacteria initially emerged in poultry and then spread to farm animals.

A team of international researchers has warned that incidences of the superbug are growing, with 500 cases seen worldwide in 2008 compared to just a handful in 2002.

They have said this particular strain of salmonella is resistant to even the most powerful of antibiotics, including ciprofloxacin, one of the most common treatments for infections caused by the bacterial illness.

The researchers also believe the emergence of antibiotic-resistant salmonella has highlighted the importance of public health surveillance in the global food industry.

Results of their findings have been published in the Journal of Infectious Diseases.

One of the researchers, Dr Simon Le Hello, from the Institut Pasteur in Paris, said: “We hope that this publication might stir awareness among national and international health, food, and agricultural authorities so that they take the necessary measures to control and stop the dissemination of this strain before it spreads globally.”

Share

Featured Articles

Healthcare business roundup: Eli Lilly, Novo Nordisk, Aspen

Eli Lilly's experimental cardiovascular drug ‘promising’; Aspen Pharmacare to manufacture mpox vaccines; Novo Nordisk says Ozempic shortage ‘worsening’

Global Health Funding 'Facing Post-Pandemic Challenges'

IHME report highlights shifting priorities and economic pressures affecting global health financing, despite increase in funding since pre-COVID levels

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

Procurement & Supply Chain

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Procurement & Supply Chain

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare